SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 43 filers reported holding SIO GENE THERAPIES INC in Q1 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $41,493 | +107.5% | 95,387 | +66.8% | 0.00% | – |
| Q2 2022 | $20,000 | -68.8% | 57,187 | -40.8% | 0.00% | – |
| Q1 2022 | $64,000 | -86.6% | 96,633 | -73.8% | 0.00% | – |
| Q4 2021 | $478,000 | +88.9% | 369,450 | +217.0% | 0.00% | – |
| Q3 2021 | $253,000 | -36.9% | 116,561 | -20.8% | 0.00% | – |
| Q2 2021 | $401,000 | -37.5% | 147,124 | -40.2% | 0.00% | – |
| Q1 2021 | $642,000 | -70.1% | 245,941 | -68.2% | 0.00% | – |
| Q4 2020 | $2,146,000 | – | 772,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,969,987 | $8,108,000 | 0.98% |
| Opaleye Management Inc. | 2,000,000 | $5,258,000 | 0.87% |
| Rubric Capital Management LP | 3,000,000 | $8,190,000 | 0.52% |
| Prosight Management, LP | 256,115 | $699,000 | 0.44% |
| ACT CAPITAL MANAGEMENT, LLC | 185,000 | $506,000 | 0.26% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,489,000 | $14,985,000 | 0.22% |
| GSA CAPITAL PARTNERS LLP | 363,887 | $993,000 | 0.11% |
| KNOTT DAVID M | 80,000 | $218,000 | 0.08% |
| Hudson Bay Capital Management LP | 1,540,000 | $4,204,000 | 0.05% |
| APOGEM CAPITAL LLC | 19,401 | $53,000 | 0.03% |